Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?
Edgewise Therapeutics Ownership Summary
Edgewise Therapeutics is owned by 106.69% institutional investors, 0.45% insiders. Orbimed advisors is the largest institutional shareholder, holding 14.79% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Edgewise Therapeutics shares.
EWTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Edgewise Therapeutics | 106.69% | 0.45% | -7.14% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 15.52M | 14.79% | $251.71M |
| Ra capital management | 10.43M | 9.94% | $169.15M |
| Baker bros. advisors lp | 7.31M | 6.96% | $118.50M |
| Blackrock | 6.02M | 6.87% | $108.34M |
| Blackrock funding, inc. /de | 6.35M | 6.05% | $103.02M |
| Paradigm biocapital advisors lp | 6.17M | 5.88% | $100.08M |
| Janus henderson group | 4.98M | 5.31% | $133.04M |
| Novo | 5.35M | 5.10% | $86.78M |
| Braidwell lp | 5.21M | 4.97% | $84.52M |
| Vanguard group | 4.80M | 4.58% | $77.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 1.03M | 38.82% | $16.71M |
| Orbimed advisors | 15.52M | 5.93% | $251.71M |
| Novo | 5.35M | 5.59% | $86.78M |
| Bioimpact capital | 1.72M | 4.57% | $27.91M |
| Cormorant asset management, lp | 4.01M | 4.49% | $65.04M |
| Paradigm biocapital advisors lp | 6.17M | 2.85% | $100.08M |
| Braidwell lp | 5.21M | 2.51% | $84.52M |
| Siren | 3.90M | 2.47% | $63.21M |
| First light asset management | 1.41M | 2.16% | $22.95M |
| Ra capital management | 10.43M | 2.08% | $169.15M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 6.02M | 0.00% | 848.71K |
| Siren | 3.90M | 2.47% | 736.80K |
| Ra capital management | 10.43M | 2.08% | 525.80K |
| Integral health asset management | 1.50M | 1.65% | 500.00K |
| Janus henderson group | 4.98M | 0.07% | 425.42K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -2.11M |
| Deep track capital, lp | - | - | -1.40M |
| Deerfield management company, l.p. (series c) | 765.69K | 0.19% | -1.30M |
| Frazier life sciences management | - | - | -1.27M |
| Ecor1 capital | - | - | -1.25M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Y-intercept (hong kong) | 57.30K | 0.02% | 57.30K | $929.41K |
| Hrt financial lp | 52.20K | 0.00% | 52.20K | $846.00K |
| Norges bank | 47.76K | 0.00% | 47.76K | $1.28M |
| Optimize financial | 27.28K | 0.23% | 27.28K | $442.53K |
| Trexquant investment lp | 22.63K | 0.00% | 22.63K | $366.98K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Creekmur asset management | -8.00 |
| Newedge advisors | -9.00 |
| Capital performance advisors llp | -20.00 |
| Stephens consulting | -30.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 176 | 1.15% | 111,963,848 | -3.66% | 106 | 0.87% | 78 | -31.58% | 61 | 60.53% |
| Jun 30, 2025 | 182 | -15.35% | 118,716,112 | 13.87% | 113 | 0.94% | 118 | 13.46% | 39 | -40.00% |
| Mar 31, 2025 | 214 | 1.42% | 105,276,596 | 6.36% | 110 | 0.99% | 104 | -14.05% | 63 | 5.00% |
| Dec 31, 2024 | 67 | -64.55% | 17,838,374 | -82.39% | 19 | 0.16% | 35 | -68.75% | 20 | -53.49% |
| Sep 30, 2024 | 188 | 33.33% | 101,300,175 | -0.31% | 107 | 0.80% | 112 | 23.08% | 43 | 48.28% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.82M | 2.68% | -62.61K |
| Vanguard US Total Market Shares ETF | 2.54M | 2.67% | -5.23K |
| iShares Russell 2000 ETF | 1.76M | 1.67% | - |
| BB Biotech AG Ord | 1.43M | 1.51% | - |
| Fidelity Small Cap Growth | 983.35K | 1.05% | -284.60K |
| Polar Capital Biotech S Inc | 975.00K | 0.93% | - |
| Artisan International Small-Mid Investor | 914.19K | 0.87% | 281.23K |
| Artisan Non-U.S. Small-Mid Growth Comp | 914.19K | 0.87% | 281.23K |
| Janus Henderson Global Life Sciences | 838.14K | 0.80% | 153.58K |
| Janus Henderson Global Life Sciences D | 838.14K | 0.80% | -8.23K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 12, 2025 | Russell Alan J | Chief Scientific Officer | Sell | $2.11M |
| Nov 11, 2025 | Fox Jonathan C | - | Buy | $199.40K |
| Aug 26, 2025 | Russell Alan J | Chief Scientific Officer | Sell | $1.46M |
| Aug 12, 2025 | MOORE JOHN R | General Counsel | Sell | $28.10K |
| Aug 12, 2025 | Derakhshan Behrad | Chief Business Officer | Sell | $33.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | 1 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | 4 | 6 |
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | 3 |
EWTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools